“Limited only by the Imagination” - Emmanuelle Charpentier awarded the Tang Prize 2016
[2016-06-20] The 2016’s Tang Prize in Biopharmaceutical Science recognizes Emmanuelle Charpentier together with Jennifer Doudna and Feng Zhang “for the development of CRISPR/Cas9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment”.
Dr. Charpentier’s research focuses on mechanisms of regulation in infection and immunity. Her laboratory strives to understand how RNA and protein molecules work together to control gene expression and biological processes in bacterial pathogens. To identify new molecules and decipher their origins, functions and modes of action at the molecular and cellular level, Dr. Charpentier applies a combination of a wide range of methods, including -omics, genetics, molecular biology, biochemistry, physiology as well as cell infection approaches.
Read more: “Limited only by the Imagination” - Emmanuelle Charpentier awarded the Tang Prize 2016